OK-432 therapy for lymphangioma in children: Why and how does it work?
- 1 April 1996
- journal article
- research article
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 31 (4) , 477-480
- https://doi.org/10.1016/s0022-3468(96)90478-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- OK-432 therapy in 64 patients with lymphangiomaJournal of Pediatric Surgery, 1994
- Induction of antitumor L3T4-positive T cells by OK-432 at tumor sites in miceCancer Immunology, Immunotherapy, 1993
- OK-432 therapy for unresectable lymphangiomas in childrenJournal of Pediatric Surgery, 1991
- Mechanism of Induction of Endogenous Tumor Necrosis Factor in Ascites of Ovarian Cancer Patients by OK-432, A Streptococcal PreparationImmunopharmacology and Immunotoxicology, 1989
- Immunotherapy using the streptococcal preparation OK-432 for the treatment of uterine cervical cancerCancer, 1987
- Intracystic injection of OK-432: A new sclerosing therapy for cystic hygroma in childrenBritish Journal of Surgery, 1987
- Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed Streptococcal preparationCancer Immunology, Immunotherapy, 1986
- Binding and Crosslinking of 125I-Labeled Recombinant Human Tumor Necrosis Factor to Cell Surface Receptors1The Journal of Biochemistry, 1986
- Intrapleural administration of OK432 in cancer patients: Activation of nk cells and reduction of suppressor cellsInternational Journal of Cancer, 1983
- Neutrophil-Mediated Tumor Cell Destruction in Cancer AscitesCancer, 1982